Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening

Affiliations


Abstract

Objective: To assess the determinants of the participation rate in breast cancer screening programs by conducting a systematic review of reviews.

Methods: We conducted a systematic search in PubMed via Medline, Scopus, Embase, and Cochrane identifying the literature up to April 2019. Out of 2258 revealed unique abstracts, we included 31 reviews, from which 25 were considered as systematic. We applied the Walsh & McPhee Systems Model of Clinical Preventive Care to systematize the determinants of screening participation.

Results: The reviews, mainly in high-income settings, reported a wide range for breast cancer screening participation rate: 16-90%. The determinants of breast cancer screening participation were simple low-cost interventions such as invitation letters, basic information on screening, multiple reminders, fixed appointments, prompts from healthcare professionals, and healthcare organizational factors (e.g. close proximity to screening facility). More complex interventions (such as face-to-face counselling or home visits), mass media or improved access to transport should not be encouraged by policy makers unless other information appears. The repeated participation in mammography screening was consistently high, above 62%. Previous positive experience with screening influenced the repeated participation in screening programs. The reviews were inconsistent in the use of terminology related to breast cancer screening participation, which may have contributed to the heterogeneity in the reported outcomes.

Conclusions: This study shows that consistent findings of systematic reviews bring more certainty into the conclusions on the effects of simple invitation techniques, fixed appointments and prompts, as well as healthcare organizational factors on promoting participation rate in screening mammography.

Keywords: Attitude to health; breast neoplasms; cancer; early detection of cancer; mass screening; oncology; patient acceptance of healthcare; patient participation; systematic review.

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The findings and views presented in this manuscript belong to the authors and do not necessarily represent the views of the organizations to which they are affiliated. Where authors are identified as personnel of the International Agency for Research on Cancer / World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer / World Health Organization. In this work the authors followed the general principles of research ethics; since the systematic review included analysis of published data, it was exempt from ethic committee review.


References

 

  1. Chen T-H, Yen A-F, Fann J-Y, et al.. Clarifying the debate on population-based screening for breast cancer with mammography: a systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model. Medicine (Baltimore)) 2017; 96: e5684. - PMC - PubMed
  2. Pasick RJ, Burke NJ. A critical review of theory in breast cancer screening promotion across cultures. Annu Rev Public Health 2008; 29: 351–368. - PubMed
  3. Walsh JM, McPhee SJ. A systems model of clinical preventive care: an analysis of factors influencing patient and physician. Health Educ Q 1992; 19: 157–175. - PubMed
  4. Nguyen BH, Stewart SL, Nguyen TT, et al.. Effectiveness of lay health worker outreach in reducing disparities in colorectal cancer screening in Vietnamese Americans. Am J Public Health 2015; 105: 2083–2089. - PMC - PubMed
  5. Daly JM, Xu Y, Levy BT. Colon polyp model use for educating about colorectal cancer screening in the Iowa Research Network. J Cancer Educ Off J UC 2014; 29: 401–406. - PMC - PubMed
  6. Lane DS, Zapka J, Breen N, et al.. A systems model of clinical preventive care: the case of breast cancer screening among older women. For the NCI Breast Cancer Screening Consortium. Prev Med 2000; 31: 481–493. - PubMed
  7. Mandrik O, Ekwunife OI, Zielonke N, et al.. What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews. Syst Rev 2017; 6: 122. - PMC - PubMed
  8. Bonfill X, Marzo M, Pladevall M, et al.. Strategies for increasing women participation in community breast cancer screening. Cochrane Database Syst Rev 2001; CD002943. - PMC - PubMed
  9. Perry N, Broeders M, de Wolf C, et al.; Europäische Kommission (eds). European guidelines for quality assurance in breast cancer screening and diagnosis. 4th ed. Luxembourg: Off. for Official Publ. of the Europ. Communities, 2006.
  10. Bulliard J-L, de Landtsheer J-P, Levi F. Participation in Swiss mammography screening programmes: key role of physicians. Praxis (Bern 1994. 2005; 94: 1381–1387. - PubMed
  11. Godin G, Kok G. The theory of planned behavior: a review of its applications to health-related behaviors. Am J Health Promot 1996; 11: 87–98. - PubMed
  12. Shea BJ, Hamel C, Wells GA, et al.. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol 2009; 62: 1013–1020. - PubMed
  13. Sin JP, St Leger AS. Interventions to increase breast screening uptake: do they make any difference? J Med Screen 1999; 6: 170–181. - PubMed
  14. Jepson R, Clegg A, Forbes C, et al.. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess Winch Engl 2000; 4: i–vii. 1–133. - PubMed
  15. Soler-Michel P, Courtial I, Bremond A. Reattendance of women for breast cancer screening programs. A review. Rev Epidemiol Sante Publique 2005; 53: 549–567. - PubMed
  16. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007; 146: 502–510. - PubMed
  17. Hamashima C.C, Hattori M, Honjo Set al.. Japanese Research Group for the Development of Breast Cancer Screening Guidelines. The Japanese Guidelines for Breast Cancer Screening. Jpn J Clin Oncol 2016; 46: 482–492. - PubMed
  18. Camilloni L, Ferroni E, Cendales BJ, et al.. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health 2013; 13: 464. - PMC - PubMed
  19. Ferroni E, Camilloni L, Jimenez B, et al.. How to increase uptake in oncologic screening: a systematic review of studies comparing population-based screening programs and spontaneous access. Prev Med 2012; 55: 587–596. - PubMed
  20. Brouwers MC, De Vito C, Bahirathan L, et al.. Effective interventions to facilitate the uptake of breast, cervical and colorectal cancer screening: an implementation guideline. Implement Sci 2011; 6: 112. - PMC - PubMed
  21. Damiani G, Basso D, Acampora A, et al.. The impact of level of education on adherence to breast and cervical cancer screening: evidence from a systematic review and meta-analysis. Prev Med 2015; 81: 281–289. - PubMed
  22. O’Malley AS, Gonzalez RM, Sheppard VB, et al.. Primary care cancer control interventions including Latinos: a review. Am J Prev Med 2003; 25: 264–271. - PubMed
  23. Bhargava S, Moen K, Qureshi SA, et al.. Mammographic screening attendance among immigrant and minority women: a systematic review and meta-analysis. Acta Radiol Stockh Radiol 2018; 59: 1285–1291. - PubMed
  24. Anderson de Cuevas RM, Saini P, Roberts D, et al.. A systematic review of barriers and enablers to South Asian women’s attendance for asymptomatic screening of breast and cervical cancers in emigrant countries. BMJ Open 2018; 8: e020892. - PMC - PubMed
  25. Abdel-Aleem H, El-Gibaly OMH, El-Gazzar A-S, et al.. Mobile clinics for women’s and children’s health. Cochrane Database Syst Rev 2016; 8: CD009677. - PubMed
  26. Edwards AGK, Naik G, Ahmed H, et al.. Personalised risk communication for informed decision making about taking screening tests. Cochrane Database Syst Rev 2013; 2: CD001865. - PMC - PubMed
  27. Bellhouse S, McWilliams L, Firth J, et al.. Are community-based health worker interventions an effective approach for early diagnosis of cancer? A systematic review and meta-analysis. Psychooncology 2018; 27: 1089–1099. - PubMed
  28. Vernon SW, McQueen A, Tiro JA, et al.. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis. J Natl Cancer Inst 2010; 102: 1023–1039. - PMC - PubMed
  29. Denhaerynck K, Lesaffre E, Baele J, et al.. Mammography screening attendance: meta-analysis of the effect of direct-contact invitation. Am J Prev Med 2003; 25: 195–203. - PubMed
  30. Moher D, Liberati A, Tetzlaff J, et al. ; The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097. - PMC - PubMed
  31. Whelehan P, Evans A, Wells M, et al.. The effect of mammography pain on repeat participation in breast cancer screening: a systematic review. Breast Edinb Breast 2013; 22: 389–394. - PubMed
  32. Donnelly TT, Khater A-HA, Al-Bader SB, et al.. Arab women’s breast cancer screening practices: a literature review. Asian Pac J Cancer Prev 2013; 14: 4519–4528. - PubMed
  33. Greenwald ZR, El-Zein M, Bouten S, et al.. Mobile screening units for the early detection of cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 2017; 26: 1679–1694. - PubMed
  34. Curbow B, Bowie J, Garza MA, et al.. Community-based cancer screening programs in older populations: making progress but can we do better? Prev Med 2004; 38: 676–693. - PubMed
  35. Sohl SJ, Moyer A. Tailored interventions to promote mammography screening: a meta-analytic review. Prev Med 2007; 45: 252–261. - PMC - PubMed
  36. Mathioudakis AG, Salakari M, Pylkkanen L, et al.. Systematic review on women’s values and preferences concerning breast cancer screening and diagnostic services. Psychooncology 2019; 28: 939–947. - PMC - PubMed
  37. Drossaert CH, Boer H, Seydel ER. Monitoring women’s experiences during three rounds of breast cancer screening: results from a longitudinal study. J Med Screen 2002; 9: 168–175. - PubMed
  38. McDaniel JT, Nuhu K, Ruiz J, et al.. Social determinants of cancer incidence and mortality around the world: an ecological study. Glob Health Promot 2019; 26: 41–49. - PubMed
  39. Hébert JR, Daguise VG, Hurley DM, et al.. Mapping cancer mortality-to-incidence ratios to illustrate racial and sex disparities in a high-risk population. Cancer 2009; 115: 2539–2552. - PMC - PubMed
  40. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137–2150. - PubMed
  41. Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries. Breast Cancer? (Auckl) 2018; 12: 1178223417752677. - PMC - PubMed
  42. Smith D, Thomson K, Bambra C, et al.. The breast cancer paradox: a systematic review of the association between area-level deprivation and breast cancer screening uptake in Europe. Cancer Epidemiol 2019; 60: 77–85. - PMC - PubMed
  43. Gianino MM, Lenzi J, Bonaudo M, et al.. Organized screening programmes for breast and cervical cancer in 17 EU countries: trajectories of attendance rates. BMC Public Health 2018; 18: 1236. - PMC - PubMed
  44. Relecom A, Arzel B, Perneger T. Effect of an organised screening program on socioeconomic inequalities in mammography practice, knowledge and attitudes. Int J Equity Health 2018; 17: 95. - PMC - PubMed
  45. Kelly DM, Estaquio C, Léon C, et al.. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys. BMJ Open 2017; 7: e016941. - PMC - PubMed
  46. Koç H, O’Donnell O, Van Ourti T. What explains education disparities in screening mammography in the United States? A comparison with The Netherlands. IJERPH 2018; 15: E1961. - PMC - PubMed
  47. Mandrik O, Ekwunife OI, Meheus F, et al. Systematic reviews as a ‘lens of evidence’: determinants of cost-effectiveness of breast cancer screening. Cancer Med 2019; 8: 7846–7858. - PMC - PubMed
  48. Mandrik O, Zielonke N, Meheus F, et al.. Systematic reviews as a ‘lens of evidence’: determinants of benefits and harms of breast cancer screening. Int J Cancer 2019; 145: 994–1006. - PMC - PubMed